| Literature DB >> 35531186 |
Sheri-Ann Tan1, Hok Chai Yam2, Siew Lee Cheong3, Yoke Chan Chow1, Chui Yin Bok1, Jia Min Ho1, Pei Yin Lee2, Baskaran Gunasekaran2.
Abstract
Porphyromonas gingivalis, the cause of periodontitis, is also linked to many systemic disorders due to its citrullination capability from a unique peptidyl arginine deiminase (PPAD). Protein citrullination is able to trigger an autoimmune response, increasing the severity of rheumatoid arthritis. The main objective of this study is to evaluate the inhibitory activity of Cratoxylym cochinchinense leaves extract towards the PPAD in vitro and in silico. Methanolic extract of Cratoxylum cochinchinense (CCM) was tested for total phenolic and flavonoid contents along with antioxidative assays. Inhibition of PPAD activities was conducted thereafter using recombinant PPAD in cell lysate. Phytocompounds postulated present in the CCM such as mangiferin, vismiaquinone A, δ-tocotrienol and α-tocotrienol and canophyllol were used as ligands in a simulated docking study against PPAD. Results obtained indicated high antioxidant potential in CCM while recording abundant phenolic (129.0 ± 2.5495 mg GA/g crude extract) and flavonoid (159.0 ± 2.1529 mg QE/g crude extract) contents. A dose-dependent inhibition of PPAD was observed when CCM was evaluated at various concentrations. CCM at 1 mg/mL exhibited citrulline concentration of 24.37 ± 3.25 mM which was 5 times lower than the negative control (114.23 ± 3.31 mM). Molecular docking simulation revealed that mangiferin and vismiaquinone A engaged in H-bonding and pi-pi interactions with important active site residues (Asp130, Arg152, Arg154 and Trp127) of PPAD and could be the potential phytochemicals that accounted for the inhibitory activities observed in the methanolic leaves extract. As such, CCM could be further explored for its therapeutic properties not only for periodontitis, but also for other systemic diseases like rheumatoid arthritis.Entities:
Keywords: ABTS, 2,2′-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) diammonium salt; ACPA, Anti-citrullinated peptide antibodies; Anti-citrullination; BAEE, Benzoyl-L-arginine ethyl ester; Cratoxylum cochinchinense; DNA, Deoxyribonucleic acid; DPPH, 2,2-diphenyl-1-picrylhydrazyl; DTT, Dithiothreitol; EDTA, Ethylenediamine tetraacetic acid; FRAP, Ferric reducing antioxidant power; GAE, Gallic acid equivalence; HPLC, High performance liquid chromatography; IPTG, Isopropyl β- d-1-thiogalactopyranoside; Mangiferin; OPLS, Optimized potentials for liquid simulations; PAD, Peptidylarginine deiminase; PCR, Polymerase chain reaction; PDB, Protein data bank; PMSF, Phenylmethylsulfonyl fluoride; PPAD, Porphyromonas gingivalis peptidylarginine deiminase; Peptidyl arginine deiminase; Porphyromonas gingivalis; QE, Quercetin equivalence; RA, Rheumatoid arthritis; SD, Standard deviation; SDS-PAGE, Sodium dodecyl sulphate–polyacrylamide gel electrophoresis; TFC, Total flavonoid content; TPC, Total phenolic content; TPTZ, 2,4,6-Tripyridyl-S-triazine; Vismiaquinone A
Year: 2021 PMID: 35531186 PMCID: PMC9073004 DOI: 10.1016/j.sjbs.2021.12.037
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.052
Fig. 1Phenolic compounds [mangiferin (1), vismiaquinone A (2), δ-tocotrienol (3), α-tocotrienol (4)] and triterpene [canophyllol (5)] previously found in the leaves extract of Cratoxylum cochinchinense.
Fig. 2DPPH (A) and ABTS (B) free radical scavenging activities and metal chelating potential (C) of Cratoxylum cochinchinense methanolic extract at different concentrations. Ascorbic acid, Trolox and EDTA are positive controls. Values are expressed as means ± SD. Asterisk represents significant difference between samples at similar concentration, p < 0.05 (A and B). Bars with alphabets a, b, c and d are significantly different from each other, p < 0.05. On the contrary, Na2EDTA across all concentrations tested are not significantly different as indicated by only alphabet d (C).
Fig. 310% SDS-PAGE analysis of the recombinant PPAD protein. Expression profile study. Lane 1 contained the uninduced sample (t = 0, negative control). Lane 2 contained the induced protein harvested at 3 h (A). Solubility of PPAD protein. Lane 3 to 6 contained soluble fractions, insoluble fractions are in Lane 7 and 8 (B). The arrows in the gels indicate the protein band of about 50 k Da corresponding to the molecular weight of recombinant PPAD protein. Lane M, protein markers in kDa.
Fig. 4Reduction of citrullination after treatment with Cratoxylum cochinchinense methanolic extract. Positive control: Cl-amidine (50 µM). Values are expressed as means ± SD. Bars with alphabets a, b, c, d, e and f are significantly different from each other, p < 0.05.
Fig. 5The superimposition of re-docked Asp-Gln dipeptide (in green) with co-crystallized dipeptide (in grey) in the binding pocket of PPAD (4YTB).
Fig. 6Binding orientations and interactions of mangiferin (highlighted in magenta) (A) vismiaquinone A (highlighted in blue) (C) in the binding pocket of PPAD (4YTB). Blue dotted line: pi-pi stacking; yellow dotted line: hydrogen bonding. 2D ligand interaction diagrams of mangiferin (B) and vismiaquinone A (D) depicting interactions between the ligand and binding site residues. Green line: pi-pi stacking; purple line: hydrogen bonding.
Docking scores of the ligands based upon Glide SP protocol.
| Compounds | Docking Scores |
|---|---|
| Mangiferin | −3.776 |
| Vismiaquinone A | −4.017 |
| δ-Tocotrienol | −3.122 |
| α-Tocotrienol | −2.723 |
| Canophyllol | −2.900 |
Fig. 7PPAD mediates the citrullination of BAEE to citrulline. Under high temperature and acidic conditions, the reaction between butanedione monoxime and the ureido groups of citrullines produces imidazolones.